Suited to general or non-prescribing neurologists, registrars looking to develop a specialism, pharmacists or established clinical nurse specialists (CNS), this course aims to provide a detailed overview of the modern management of MS across diagnosis and treatment. With in-depth learning around disease-modifying treatments (DMTs), including the safe use and monitoring of them, and areas for especial monitoring and care to avoid serious adverse events.
Promoting active and holistic management of MS throughout the applied-learning model and with inspiring speakers sharing their experiences and expertise, the course seeks to inspire attendees to implement change and optimise care for their own patients. With a large component of the course focussing on setting-up and running a comprehensive MS service and an intermodule project encouraging really practical research into attendees own local practice, the Intermediate MasterClass is both a learning experience and a catalyst for change.
To complete the course: Delegates must complete all aspects of module 1, the inter-module project, and module 2 to gain their certificate. Projects, which should epitomise learning in practice and focus on an unmet need locally, will be presented to their peers and faculty within module 2.
The course is fully funded across both modules including travel allowance for clinicians practising in the UK.
Upcoming Intermediate MasterClasses
► MS Intermediate MasterClass 11 – Module 1
07/10/2020 - 09/10/2020
► MS Intermediate MasterClass 11 – Module 2
03/12/2020 - 04/12/2020
|Module 1 of this MasterClass has been postponed to October 2020. Dates for module 2 are still being confirmed. If you have any queries please do not hesitate to contact us.|
How are the courses taught?
The courses are taught through a range of learner-centred methods including formal lectures, interactive workshops, and an intermodule project. Additional seminars and learning opportunities will be undertaken more locally with your mentor and through distance learning. Learners must complete an intermodule workplace service project during the six/eight month break before returning to Module 2 to present their findings.
A note from our Academic Director, Prof Gavin Giovannoni:
‘To cement the learning objectives from your first MasterClass module, its essential that you complete a project that builds on that learning.
Choose a project that addresses an unmet need in your local service, and find something that sparks your interest. Talk it through with your mentor – or come find me at module 1. We don’t want you to choose something ‘quick and easy’ or to present a proposal or case discussion. Without this project you cannot pass the course or receive your CPD certificate – but we don’t want you to look at it as a ‘tickbox’ to complete. We want to see you putting you’re learning into practice.
Our ambition is for your projects to be the catalyst for change in your practice – to see them improve outcomes for people with MS.’
Needing some project inspiration or wondering what past delegates have done? Take a look at our Snapshots or read about the work of some of our faculty members from the flagship Parkinson’s Academy established 16 years ago.
What will it cost?
The courses are fully funded which includes accommodation on the nights during Module 1 and if required the night prior to the course. Accommodation is available for the night prior to Module 2. Your travel grant will be discussed once your application has been approved and is for UK delegates only. Please note, international delegates are responsible for their own travel arrangements.
We welcome International delegates on the MS courses, however there is a charge of £1000 including VAT for each place, you are also required to cover your own travel costs. Your fee will cover accommodation during the MasterClass, meals, course materials and sessions over the 3 days and for the return of the module 2. Please note that there may be bank charges with your transfer of funds, so please do ensure you contact us prior to making any payment.
This activity has been supported by sponsorship from Roche Products Limited, Biogen Idec Limited and Sanofi Genzyme. The sponsors have had no control over the educational content of this activity.